Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endothelial Cell Specific Molecule-1 (Endocan) Levels in Women With Premature Ovarian Insufficiency

NCT03924648 is registered in ClinicalTrials.gov with Cengiz Gokcek Women's and Children's Hospital as lead sponsor.

NCT NCT03924648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03924648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endothelial Cell Specific Molecule-1 (Endocan) Levels in Women With Premature Ovarian Insufficiency
Lead sponsor
Cengiz Gokcek Women's and Children's Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2018
Completion date
April 1, 2019
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ovarian failure